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Evaluation of vitamin B12 level in middle-aged obese women
with metabolic and nonmetabolic syndrome: case-control study
Davut BALTACI1, Ali KUTLUCAN2, Serkan ÖZTÜRK3, İsmail KARABULUT4, Hayriye AK YILDIRIM5,
Ahmet ÇELER1, Gökhan CELBEK2, İsmail Hamdi KARA1

Aim: To investigate the correlation between vitamin B12 and body mass index (BMI) along with insulin resistance (IR)
in middle-aged obese women.
Materials and methods: The study was designed as a case-control study. The study group included middle-aged obese
women and the control group included aged-matched lean women. Weight, height, and hip and waist circumferences
were measured. Biochemical parameters such as fasting and postprandial glucose, vitamin B12 and folic acid levels, and
lipid profiles were assayed.
Results: Enrolled in the study were 116 middle-aged obese and 103 aged-matched healthy lean women. The vitamin B12
level of the obese women was significantly lower than that of the lean women (244.1 ± 131.5 pg/mL vs. 336.2 ± 163.1
pg/mL, P = 0.002). However, there was no significant difference in folic acid levels between the groups (P > 0.05). The
vitamin B12 level was similar in the obese women with metabolic syndrome and those without (245.1 ± 145.3 pg/mL
vs. 241.2 ± 96.5 pg/mL, P > 0.05), but the level in the control group was significantly higher than that of patients with
obesity and metabolic syndrome (P = 0.010 and P = 0.020, respectively). Vitamin B12 levels correlated with BMI (r =
–0.259, P = 0.003) but not with IR (r = –0.053, P > 0.05).
Conclusion: The vitamin B12 concentration was low in obese patients and this level negatively correlated with BMI, but
not with homeostasis model assessment-estimated IR (HOMA-IR).
Key words: Obesity, vitamin B12, insulin resistance, body mass index

Introduction
Obesity and vitamin B12 deficiency are common
health problems encountered in primary care
settings. Obesity is associated with many diseases.
People with obesity are at great risk for some diseases
such as diabetes mellitus and cardiovascular diseases.
In patients with obesity who also have metabolic
syndrome (MetS) and those without, the metabolic
state is changed and many inflammatory cytokines,

such as interleukins, tumor necrosis factors, and
C-reactive proteins, are increased (1-3). A number
of diseases not classically considered to be caused
by vitamin B12 deficiency are epidemiologically
associated with it, raising questions of whether
vitamin B12 status is an independent risk factor or
a partial causal agent in these states. None of these
causal links have been proven and all are under active
investigation (4,5).

Received: 04.05.2011 – Accepted: 17.11.2011
1
Department of Family Medicine, Faculty of Medicine, Düzce University, Düzce - TURKEY
2
Department of Internal Medicine, Faculty of Medicine, Düzce University, Düzce - TURKEY
3
Department of Cardiology, Faculty of Medicine, Abant İzzet Baysal University, Bolu - TURKEY
4
Department of Physiology, Faculty of Medicine, Hacettepe University, Ankara - TURKEY
5
Department of Biochemistry, Faculty of Medicine, Düzce University, Düzce - TURKEY
Correspondence: Davut BALTACI, Department of Family Medicine, Faculty of Medicine, Düzce University, Düzce - TURKEY
E-mail: davutbaltaci@hotmail.com

802

D. BALTACI, A. KUTLUCAN, S. ÖZTÜRK, İ. KARABULUT, H. AK YILDIRIM, A. ÇELER, G. CELBEK, İ. H. KARA

The total amount of vitamin B12 stored in the
body is about 2-5 mg in adults. Approximately
50% of this is stored in the liver (6,7). Vitamin B12
deficiency is usually due to pernicious anemia and an
inadequate intake of nutrition enriched with vitamin
B12, especially among vegetarian people. Various
cutoff values for vitamin B12 have been propounded.
Currently, there is no certain agreement on the
clinical use of cutoff levels for vitamin deficiency. A
recent widely used clinical cutoff level for vitamin
B12 deficiency was 148 pmol/L (200 pg/mL) (8).
In the literature, some studies investigated
vitamin B12 levels in obese patients, with MetS or
without, and tried to find a relation between vitamin
B12 deficiency and obesity. They reported different
results. While vitamin B12 levels were normal in
some, levels were low in others. Uehara and Rosa
(9) reported that cobalamin levels were normal in
their study. Guven et al. (10) also found that vitamin
B12 levels were normal. However, Karatela et al. (11)
conducted a study on vitamin B12 and homocysteine
levels in hypertensive patients who were obese and
overweight compared to normal-weight hypertensive
patients, reporting a high homocysteine level and
reduced vitamin B level. Moreover, Pinhas-Hamiel et
al. (12) conducted a study on vitamin B12 levels and
obesity in children and adolescents and found that
obesity was associated with vitamin B12 deficiency.
The purpose of the present study was to investigate
the association between vitamin B12 and obesity,
the correlation between vitamin B12 deficiency
and anthropometric measurements, and insulin
resistance (IR) in middle-aged obese women with
and without MetS.
Materials and methods
The study design and patients
The case-control study was conducted at the
outpatient clinic of the Family Medicine Department
at Düzce University, between June and December
2010, in Düzce, Turkey. Women who met the study
obesity criteria were included. Age-matched, lean,
healthy women were enrolled in the control group.
Exclusion criteria included being a strict vegetarian,
being male, being over 50 years of age, current use
of corticosteroids or vitamin supplementations, long-

term use of proton pump inhibitors (PPIs; 3 months
or longer) and metformin, and diabetes mellitus.
Informed consent was obtained. Ethical approval was
given by the ethics committee of our institute.
Anthropometric measurements
The anthropometric values of the participants
from the study and control groups were measured:
fasting body weight, height, and waist and hip
circumferences were measured in the morning,
according to standard procedures. Weight and
height were measured with the subjects wearing light
clothing and without shoes. Height was recorded to
the nearest 0.1 cm with a stadiometer. Weight was
recorded to the nearest 0.1 kg using a balance-beam
scale. Waist circumference was measured to the
nearest 0.1 cm at the midpoint between the bottom
of the rib cage and the top of the iliac crest, at the end
of exhalation, using a waistline measurer employed
with subjects standing without clothing covering the
waist area. Hip circumference was measured to the
nearest 0.1 cm using a tape applied with the subjects
standing and without clothing except for light
underwear covering the hip area around the point
with the maximum circumference over the buttocks.
Body mass index (BMI) was calculated using the
following formula: kg / height (m2).
Biochemical analysis
All of the blood and urinary samples were collected
in the morning, after 8-12 h of overnight fasting.
After blood was drawn, the tubes were gently shaken
and then separated by centrifugation at 3200 rpm
for 10-15 min. A blood sample for postprandial
glucose level was drawn 2 h after eating. A blood
sample for complete blood count test was drawn
into a tube containing ethylenediaminetetraacetic
acid (EDTA). Lipid profiles were assayed using the
colorimetric method (Cobas 6000 C 501, Roche
Diagnostics GmbH, Mannheim, Germany). Insulin,
thyroid-stimulating hormone, vitamin B12, and
folic acid levels were assayed using the solid-phase
2-site chemiluminescent immunometric assay,
solid-phase competitive chemiluminescent enzyme
immunoassay,
solid-phase
chemiluminescent
immunometric assay, and competitive immunoassay,
respectively (IMMULITE 2000, Siemens Healthcare
Diagnostics, Flanders, NJ, USA). Low density
lipoprotein-cholesterol (LDL-C) was calculated
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using the Friedewald formulation. Homeostasis
model assessment-estimated IR (HOMA-IR) was
also calculated with the following formula: fasting
serum glucose (mg/dL) × fasting plasma insulin level
(μU/mL) / 405. HOMA-IR was accepted as positive if
it was >2.5 (13).
Determination of obesity, metabolic syndrome, and
vitamin B12 deficiency
Obesity was defined as a BMI value over 29.9 kg/
m2, as described by the World Health Organization
(14). MetS was defined, using criteria proposed by
the National Cholesterol Education Program Adult
Treatment Panel III, as 3 or more of the following
variables and cutoff points: 1) fasting blood sugar
of ≥110 mg/dL, 2) triglyceride level of ≥150 mg/dL,
3) high-density lipoprotein cholesterol (HDL-C) of
<50 mg/dL in women, 4) waist circumference of >88
cm, and 5) blood pressure of ≥130/85 mmHg (13).
In our study, we used 3 descriptive cutoff points for
the status of vitamin B12, as suggested by Tucker et
al. (15). Accordingly, the current clinical cutoff was
200 pg/mL (148 pmol/L), the intermediate point
was 250 pg/mL (185 pmol/L), and a point at which
individuals may be at risk of deficiency was 350 pg/
mL (258 pmol/L), although further testing is then
needed.

Statistical analysis
Data were analyzed using SPSS 15.0 (SPSS Inc.,
Chicago, IL, USA). Data were expressed as means ±
standard deviations, medians (interquartile range), or
percentages (%). Student’s t-test was used to compare
statistical differences of normal variables among the
different groups, but for skewed variables, a MannWhitney U test or Kruskal-Wallis H test was used.
One-way ANOVA (Bonferroni test) was used to
compare statistical differences for variables of more
than 2 groups. Correlation between vitamin B12
levels and BMI and HOMA-IR was analyzed using
Pearson’s correlation analysis. A 2-tailed P-value of
less than 0.05 was considered statistically significant.
Results
Sociodemographic and clinical features of the study
subjects
A total of 116 middle-aged obese women (obesity
with MetS: 81, obesity without MetS: 35) and 103
aged-matched healthy lean women were included
in the study and control groups, respectively. Some
sociodemographic features of the total participants
are shown in Table 1.

Table 1. Distribution of sociodemographic features and findings of the study and control groups.
Study group
(n = 116) (%)

Control group
(n = 103) (%)

P*

Age

37.7 ± 9.1

35.3 ± 8.2

0.236**

Status of smoking
Smoker
Nonsmoker

18 (15.5%)
98 (84.5%)

15 (14.6%)
88 (85.4%)

0.620

Status of occupation
Working
Not working (housewife)

19 (16.4%)
97 (83.6%)

81 (78.6%)
22 (21.4%)

<0.0001

Alcohol use
Yes
No

2 (1.7%)
114 (98.3%)

3 (2.9%)
100 (97.1%)

0.730

Total

116 (100%)

103 (100%)

Parameters

*Fischer’s exact/chi-square tests were used to compare categorical variables between the study and
control groups. P < 0.05 was accepted as statistically significant.
**Independent Student’s t-test was used for comparison of the mean age between the study and control
groups. There was no significant difference observed (P = 0.236).
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Biochemical and anthropometric parameters of
subjects in the study group
In Table 2, a comparison of the biochemical and
anthropometric parameters in the study and
control groups is shown. HOMA-IR value, HDL-C,
triglycerides (TG), and anthropometric and blood
pressure measurements in the study group were
statistically different from those in the control group
(P = 0.0001, P = 0.001, P = 0.0001, and P = 0.0001,
respectively). However, total cholesterol (total-C),
low-density lipoprotein cholesterol (LDL-C), folic
acid level, and complete blood counts [hemoglobin
(Hb), hematocrit, and mean corpuscular volume
(MCV)] were not significant between the 2 groups
(P > 0.05). The vitamin B12 level in the obese group
was significantly lower than in the control group
(244.1 ± 131.5 pg/mL vs. 336.2 ± 163.1 pg/mL; P =
0.002). The study group was divided into subgroups,
as obese with MetS and obese without. We compared
the BMI, vitamin B12 level, folic acid level, HOMAIR, lipid profile, measurement of blood pressure,
and anthropometric measurements of the subgroup

patients with those of the control group. The results
are shown in Table 3. Accordingly, the mean BMI
in the obese women with MetS and without was
significantly higher than those in the control group
(36.2 ± 6.6 kg/m2 and 33.2 ± 4.3 kg/m2 vs. 23.3 ± 2.4
kg/m2; P < 0.0001). The average waist circumference
measurement of the lean women was significantly
lower than those of the obese women with MetS and
without (84.2 ± 7.8 cm vs. 105.4 ± 12.1 cm and 98.6
± 9.6 cm; P < 0.0001 and P < 0.0001). Furthermore,
the mean waist circumference of patients with only
obesity was significantly different from those of
patients with obesity and MetS (P < 0.0001). The mean
hip circumference measurement of the obese women
with MetS and without was statistically higher than
that of the control group (112.3 ± 15.1 cm and 104.9
± 16.6 cm vs. 92.8 ± 18.6 cm; P < 0.0001). The mean
HDL-C level was significantly lower in patients with
MetS, compared to the lean and obese subjects (40.5 ±
9.2 mg/dL vs. 52.8 ± 13.8 mg/dL and 54.7 ± 13.3 mg/
dL; P < 0.0001 and P > 0.05). The mean HOMA-IR
in the participants (obese with MetS, obese without

Table 2. Comparisons of the anthropometric and biochemical parameters between the patients and the
control group.
Study group
(n = 116)

Control group
(n = 103)

P*

Anthropometric measurements
BMI (kg/m2)
Waist circumference (cm)
Hip circumference (cm)

36.7 ± 6.3
103.7 ± 12.1
110.6 ± 15.5

23.3 ± 2.4
84.2 ± 7.8
92.8 ± 18.4

<0.0001
<0.0001
<0.0001

Lipid profile (mg/dL)
LDL-C (mg/dL)
HDL-C (mg/dL)
TG (mg/dL)
Total-C (mg/dL)

107.1 ± 32.3
44.8 ± 12.3
151.4 ± 87.4
183.7 ± 37.1

96.1 ± 26.6
52.8 ± 13.8
95.7 ± 47.4
174.7 ± 51.7

0.046
0.001
<0.0001
0.299

HOMA-IR

3.04 ± 2.26

1.32 ± 1.13

<0.0001

Blood pressure (mmHg)
Systolic
Diastolic

129.6 ± 11.3
84.3 ± 8.4

112.6 ± 6.3
71.8 ± 4.8

<0.0001
<0.0001

B12 vitamin level (pg/mL)

244.1 ± 131.5

336.2 ± 163.1

0.002

Folic acid level (pg/mL)

8.9 ± 6.7

6.7 ± 3.2

0.058

Complete blood count
Hb (g/dL)
MCV (μm3)

12.3 ± 1.6
81.2 ± 5.7

12.7 ± 1.1
82.1 ± 5.7

0.083
0.421

Parameters

*Student’s t-test was used. P< 0.05 was accepted as statistically significant.
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Table 3. Comparisons of anthropometric and biochemical parameters in women with obesity and MetS with lean healthy women.

Parameters

MetS
(n = 81)

Obesity
(n = 35)

Control
(n = 103)

P*

Age (years)

39.8 ± 8.6

35.3 ± 7.2

35.1 ± 8.3

>0.05

36.9 ± 6.2
105.4 ± 12.1
112.3 ± 15.1

33.2 ± 4.3
98.6 ± 9.6
104.9 ± 16.6

23.3 ± 2.4
84.2 ± 7.8
92.8 ± 18.4

<0.0001
<0.0001
<0.0001

3.5 ± 2.5

2.1 ± 2.5

1.3 ± 1.1

0.001, <0.001, >0.05

Blood pressure (mmHg)
Systolic blood pressure
Diastolic blood pressure

132.1 ± 10.3
86.3 ± 7.5

123.7 ± 11.1
79.6 ± 8.7

112.6 ± 6.3
71.8 ± 4.8

<0.001
<0.001

Lipid profile
LDL-C (mg/dL)
HDL-C (mg/dL)
TG (mg/dL)
Total-C (mg/dL)

108.4 ± 32.5
40.5 ± 9.2
170.5 ± 98.2
183.7 ± 39.2

104.5 ± 33.2
54.7 ± 13.3
108.5 ± 32.4
184.1 ± 33.5

96.1 ± 26.6
52.8 ± 13.8
95.7 ± 47.4
174.7 ± 51.7

>0.05
<0.001, >0.05
<0.001, >0.05
>0.05

B12 vitamin level (pg/mL)

245.1 ± 145.3

241.2 ± 96.5

336.2 ± 163.1

0.010, 0.002, >0.05

9.1 ± 7.8

8.4 ± 3.9

6.8 ± 3.3

>0.05

Anthropometric measurements
BMI (kg/m2)
Waist circumference (cm)
Hip circumference (cm)
HOMA-IR

Folic acid level (pg/mL)

*ANOVA (Bonferroni test) was used. P < 0.001 was accepted as statistically significant.

MetS, and lean women) was 3.4 ± 2.5, 2.1 ± 2.5,
and 1.3 ± 1.1, respectively. A statistically significant
difference was found between the obese women with
MetS and without (P = 0.001) and between the obese
women with MetS and lean women (P < 0.001), but
not between the obese women without MetS and the
lean women (P > 0.05).
Vitamin B12 levels in the lean patients were
significantly higher than in patients with obesity with
and without MetS (336.2 ± 163.2 pg/mL vs. 245.1 ±
145.3 pg/mL and 241.1 ± 96.5 pg/mL; P = 0.010 and
P = 0.020, respectively). However, a comparison of
vitamin B12 levels between obesity with MetS and
obesity without MetS was not significant (P > 0.05),
although the mean B12 level in patients with MetS
was slightly higher (Table 3).
Correlation of vitamin B12 and folic acid level with
insulin resistance
In Table 4, vitamin B12 and folic acid levels in the
obesity group were compared to the status of HOMA806

IR. The vitamin B12 level in subjects with HOMA-IR
(+) (n = 54) was lower than in those with HOMAIR (–) (n = 62), but no significant difference was
detected (278.2 ± 152.7 pg/mL vs. 249.6 ± 131.5 pg/
mL, P > 0.05; 7.8 ± 3.5 pg/mL vs. 9.3 ± 9.1 pg/mL, P
> 0.05). A negative correlation between vitamin B12
levels and both IR and BMI was observed, but it was
only statistically significant with BMI (r = –0.237, P =
0.003; r = –0.058, P = 0.447, respectively).
Comparison of vitamin B12 levels in subjects
according to different cutoff values
Table 5 shows the number of obese participants
with and without MetS and the control group, and
the comparison with the cutoff value of vitamin B12
levels. Here, there were significant differences in the
number of subjects according to 3 vitamin B12 cutoff
value classifications. The cutoff value classification
was set as 200 pg/mL and the majority of the obese
patients with MetS were under this cutoff value (n
= 41, 50.6%), while only 20.3% of the control group
individuals (n = 21) were under this value.
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Table 4. Vitamin B12 concentration according to HOMA-IR status in women with obesity.

Parameters

HOMA-IR (–)
(n = 62)

HOMA-IR (+)
(n = 54)

P*

B12 vitamin level (pg/mL)

278.2 ± 152.7

249.6 ± 131.5

0.245

7.8 ± 3.5

9.3 ± 9.1

0.211

Folic acid level (pg/mL)

*Student’s t-test was used. P < 0.05 was accepted as statistically significant.

Table 5. Correlation of vitamin B12 concentration with BMI and HOMA-IR.
BMI (kg/m2)

B12 vitamin level (pg/mL)

HOMA-IR

r

P*

r

P*

–0.237

0.003

–0.058

0.447

*Pearson’s correlation analysis was used to analyze the correlation of vitamin B12, BMI, and IR. P < 0.05
was accepted as statistically significant.

Discussion
We found that middle-aged obese women had
significantly lower vitamin B12 levels than normal
lean women. We also detected that serum vitamin
B12 levels were negatively correlated with BMI.
Vitamin B12 deficiency results from an
inadequate intake of nutrition, abnormal nutrient
absorption, and rare inborn errors of vitamin B12
metabolism. Vitamin B12 is mainly present in animal
protein, particularly organ meats, bivalves, and, to a
lesser extent, in seafood, milk, and milk products.
However, prevalence of vitamin B12 deficiency is not
rare, and it is especially common the elderly. Vitamin
B12 deficiency does not only cause anemia and
megaloblastic anemia, but also causes neurological
symptoms. Recent studies have shown that longterm use of metformin decreases vitamin B12 levels
in patients, especially diabetic patients (17,18).
Therefore, we excluded the patients who had used
metformin for a long period of time.
A correlation between obesity and vitamin B12
levels has been investigated in a few studies. Guven et
al. (10) conducted a study on plasma homocysteine
and lipoprotein levels in patients with MetS and
found low levels of vitamin B12 compared to normal
healthy individuals. We studied vitamin B12 and folic

acid levels, but not homocysteine levels, and we also
found that vitamin B12 levels were low but that folic
acid levels were normal.
IR is a metabolic assault. It is associated with
many undesired medical conditions. In diseases
with IR (+), a proinflammatory state is activated.
IR does not develop in every obese patient. The
correlation between vitamin B12 levels and IR is
not clear. Cemil et al. (19) conducted a study on the
relation between IR and plasma vitamin B12 levels
in women with polycystic ovary syndrome, and they
found that vitamin B12 levels were lower in obese
women with IR compared to those without IR. In the
present study, there were 62 subjects with IR (–) and
54 subjects with IR (+) in the obese group. None of
the women in the control group had IR [HOMA-IR
(+)]. We compared the correlation between the obese
women with IR (+) and IR (–), using HOMA-IR. We
did not find any significant difference. We observed a
negative correlation, but it was not significant. On the
other hand, Tungtrongchitr et al. (20) studied serum
homocysteine, vitamin B12, and folic acid levels in
overweight and obese subjects and they found no
statistically significant difference in the vitamin
B12 levels compared with normal weight subjects.
Reitman et al. (21) conducted a study on plasma
807
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antioxidants, vitamin B12, and homocysteine levels
in patients with obesity and found no significant
difference in vitamin B12 levels between the obese
and lean subjects. In contrast, the present study
indicated that vitamin B12 levels were significantly
lower in the obese patients compared to the normal
subjects, and we found no significant difference in
folic acid levels between the obese and nonobese
women.
In our study, we did not only compare vitamin
B12 levels in obese and lean middle-aged women, but
also in patients with MetS. We detected no significant
difference between the obese women with and
without MetS. However, we found that vitamin B12
levels in the control group were significantly different
from those of both the obese women with MetS and
those without. In our study, we used a classification
for vitamin B12 levels that was suggested by Tucker
et al (15), since it was widely used in clinical practice.
According to this classification, the majority of
patients with MetS and obesity were under the
vitamin B12 level cutoff value. When we observed
the 3 vitamin B12 level cutoff values, we detected
a significant difference in the number of patients
between the study and control groups (obesity and
MetS). As a result, we declare only that obesity might
be risk factor, but not that it is a causal factor because
further community-based study is required.
A few studies have demonstrated that long-term
use of PPIs caused vitamin B12 deficiency in patients
with dyspeptic symptoms (22). In our study, the
patients who had used PPIs for over 3 months were
excluded. Chronic but intermittent (short-interval)
use of PPI in the population is not rare. Van Oijen
et al. (23) studied the association between BMI and
prevalence of gastrointestinal symptoms and found
that there was a small but not statistically significant
increase in the prevalence of gastrointestinal diseases
and related symptoms. We know that chronic but

intermittent use of PPIs is common in the Turkish
population in middle-aged women (24-26).
In the present study, BMI, HDL-C, TG, blood
pressure, and anthropometric measurements were
significantly different in patients with obesity and
MetS compared to the control group. Moreover,
another interesting result in our study was that the
majority of women with obesity were not working
or were housewives. This indicates that actively
participating in social life and having a social role are
important for sociopsychological impact (27).
There were some limitations in our study.
First, homocysteine levels were not evaluated.
In some studies, it was shown that there was a
relation between homocysteine and vitamin B12
concentrations. Second, long-term use of PPIs in our
patients was examined, but intermittent use of PPIs
was not. Intermittent use of PPIs might be effective at
lowering vitamin B12 levels. Third, it was shown that
there was a relation between vitamin B12 deficiency
and H. pylori manifestation in previous studies. We
did not investigate the state of H. pylori.
In the present study, vitamin B12 levels were low
in middle-aged obese women with and without MetS.
The more the BMI increases, the lower the vitamin
B12 level is in middle-aged women. We observed
that vitamin B12 levels in obese women correlated
with BMI but not with IR. The causes of obesity are
multifactorial diseases and the intake of imbalanced
nutrition, as well as a sedentary lifestyle. Obesity is an
ill-balanced medical condition and carries many risk
factors for metabolic and cardiovascular diseases.
Therefore, we should advise the implementation of a
well-balanced diet.
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